RecruitingNCT06736847

Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric Cancer

Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery Following D2 Lymphadenectomy Plus Complete Mesogastric Excision in Patients Who Received Distal Gastrectomy: A Prospective Observational Study


Sponsor

Jichao Qin

Enrollment

200 participants

Start Date

May 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to evaluate lymph node metastasis and tumor deposit in the posterior gastric mesentery following distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is examining surgical specimens from patients who underwent surgery for distal (lower) gastric cancer to better understand how cancer spreads to nearby lymph nodes — specifically in an area called the posterior gastric mesentery — to improve surgical techniques. **You may be eligible if...** - You are between 18 and 85 years old - You have been diagnosed with primary stomach (gastric) adenocarcinoma - Your cancer is Stage T2–T4, N0–N3, with no distant spread (M0) - You underwent distal gastrectomy with D2 lymph node dissection and complete mesogastric excision **You may NOT be eligible if...** - Your preoperative biopsy was negative - Your cancer was too advanced (T4b or metastatic M1) - Your BMI is over 30 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREdistal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer

distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer


Locations(1)

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06736847


Related Trials